Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 2 |
2021 | 2 |
2022 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Point of Care Molecular Testing: Community-Based Rapid Next-Generation Sequencing to Support Cancer Care.
Curr Oncol. 2022 Feb 23;29(3):1326-1334. doi: 10.3390/curroncol29030113.
Curr Oncol. 2022.
PMID: 35323313
Free PMC article.
A Guide to Implementing Immune Checkpoint Inhibitors within a Cancer Program: Experience from a Large Canadian Community Centre.
Cheema PK, Iafolla MAJ, Nematollahi M, Berco F, Kaushik D, Matthews P, Raskin WR, Perdrizet KA, Dudani S, Husain J, Balcewicz M, Kuruvilla PG, Reingold SM, Conter HJ.
Cheema PK, et al. Among authors: raskin wr.
Curr Oncol. 2022 Feb 4;29(2):869-880. doi: 10.3390/curroncol29020074.
Curr Oncol. 2022.
PMID: 35200573
Free PMC article.
Item in Clipboard
The impact of early palliative care: a medical oncologist's perspective.
Raskin W.
Raskin W.
Ann Palliat Med. 2020 May;9(3):1292-1295. doi: 10.21037/apm.2019.10.02. Epub 2019 Nov 20.
Ann Palliat Med. 2020.
PMID: 31865742
Free article.
Item in Clipboard
The Association of Drug-Funding Reimbursement With Survival Outcomes and Use of New Systemic Therapies Among Patients With Advanced Pancreatic Cancer.
Raphael MJ, Raskin W, Habbous S, Tai X, Beca J, Dai WF, Arias J, Forbes L, Gavura S, Biagi JJ, Earle CC, Chan KKW.
Raphael MJ, et al. Among authors: raskin w.
JAMA Netw Open. 2021 Nov 1;4(11):e2133388. doi: 10.1001/jamanetworkopen.2021.33388.
JAMA Netw Open. 2021.
PMID: 34779846
Free PMC article.
Item in Clipboard
Feasibility outcomes of a randomised, multicentre, pilot trial comparing standard 6-monthly dosing of adjuvant zoledronate with a single one-time dose in patients with early stage breast cancer.
Awan A, Ng T, Conter H, Raskin W, Stober C, Simos D, Pond G, Dhesy-Thind S, Mates M, Kumar V, Fergusson D, Hutton B, Saunders D, Vandermeer L, Clemons M; REaCT Investigators.
Awan A, et al. Among authors: raskin w.
J Bone Oncol. 2020 Dec 13;26:100343. doi: 10.1016/j.jbo.2020.100343. eCollection 2021 Feb.
J Bone Oncol. 2020.
PMID: 33425673
Free PMC article.
Item in Clipboard
Cite
Cite